Systematic ReviewResearchMedication SafetyPatient Education

Review found no formal pediatric guidelines for deprescribing psychotropic medications

Basic & Clinical Pharmacology & Toxicology (PubMed)Jul 24, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A systematic search of pediatric psychotropic deprescribing guidance found no publication that met the review's criteria for a formal clinical practice guideline, exposing a major evidence and implementation gap for children and adolescents.

What NurseJet pulled from the source

From 1,390 records, the reviewers appraised two papers with practical recommendations resembling guidelines: one on antidepressant discontinuation and one mainly on stimulants. Both were rated moderate quality and provided limited stepwise detail. The authors supplemented the review with an expert-informed algorithm, which should not be mistaken for a validated pediatric guideline.

Why this matters for nurses

Pediatric and mental-health nurses may detect withdrawal symptoms, recurrence, adverse effects, adherence concerns, and family questions during medication changes. The review reinforces coordinated, individualized monitoring while showing that apparent practical detail should not be confused with a high-certainty pediatric standard.

Bedside takeaway

Pediatric psychotropic deprescribing lacks formal guidelines, making prescriber-led plans and careful symptom monitoring essential.

How This Applies in Practice

Use this when: Supporting a child or adolescent during a prescriber-directed psychotropic dose reduction or discontinuation.

On your shift

Confirm the medication-specific taper, follow-up interval, monitoring measures, and escalation plan before reinforcing education.
Document dose timing, withdrawal-like symptoms, symptom recurrence, sleep, function, safety concerns, and family observations.
Promptly route unclear instructions, worsening symptoms, or safety concerns to the prescriber and pharmacist.

Keep in mind: The review found no formal pediatric guideline, and its expert-informed algorithm is not a substitute for individualized care. Follow the medication protocol, facility policy, and patient-specific provider orders.

Explain this for my unit

Key takeaways

The search covered six bibliographic and grey-literature sources from 2015 through 2025.
No identified publication met the methodological criteria for a formal pediatric psychotropic deprescribing guideline.
Two moderate-quality papers offered limited recommendations for antidepressants or stimulants.
The proposed stepwise algorithm incorporates clinical expertise and has not been validated as a guideline or outcome-improving intervention.

Practice implications

Clarify the prescriber-led taper and monitoring plan, establish the symptoms and safety concerns that require escalation, and document medication timing, withdrawal-like symptoms, recurrence, sleep, function, and family observations. Avoid abrupt or independent medication changes.

Limitations & cautions

No formal guideline met the inclusion criteria, and only two moderate-quality recommendation papers informed the review. The authors' algorithm was supplemented by expert opinion and has not been prospectively validated for safety, effectiveness, drug classes beyond the limited evidence, or diverse care settings.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Open source

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Basic & Clinical Pharmacology & Toxicology (PubMed)

Basic & Clinical Pharmacology & Toxicology (PubMed). Deprescription of Psychotropics in Children and Adolescents: Systematic Review of Guidelines and Development of a Deprescribing Algorithm.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42496669/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Journal of Obstetrics and Gynaecology Research (PubMed)Jul 24, 2026Systematic ReviewPractice applicable

A systematic review and meta-analysis of 11 randomized trials involving 3,783 participants found that oral misoprostol was associated with fewer cesarean births and less oxytocin augmentation than vaginal dinoprostone, while dinoprostone was associated with faster delivery outcomes.

L&D / OB Med-SurgAI summaryReview source

Systematic ReviewResearchMedication SafetyWorkflowPractice applicableAI summary · original source linked below

The review included singleton pregnancies at 34 weeks or later undergoing labor induction. Oral misoprostol was associated with lower cesarean birth (risk ratio 0.83) and less oxytocin augmentation (risk ratio 0.89). Vaginal dinoprostone was associated with more vaginal births within 24 hours and a shorter induction-to-birth interval. The analysis found no significant differences in uterine hyperstimulation, low five-minute Apgar scores, or NICU admission.

Key takeaways

Eleven randomized trials with 3,783 participants compared oral misoprostol with vaginal dinoprostone.
Cesarean birth and oxytocin augmentation were less frequent in the oral-misoprostol groups.
Vaginal birth within 24 hours and a shorter induction-to-birth interval favored vaginal dinoprostone.
The pooled safety outcomes did not differ significantly, but clinical and methodological heterogeneity limits a one-size-fits-all conclusion.

Why this matters on shift

Labor and delivery nurses administer cervical-ripening agents, assess uterine activity and fetal status, and coordinate oxytocin and escalation. The findings clarify that the two approaches involve different delivery and resource-use tradeoffs rather than establishing one universally preferred regimen.

Bedside takeaway

Oral misoprostol and vaginal dinoprostone showed different labor-induction tradeoffs, reinforcing protocol-based administration and monitoring.

Nursing implications

Use the ordered induction pathway for route, dose, interval, monitoring, and oxytocin timing. Document uterine activity, fetal response, cervical change, and adverse effects, and escalate tachysystole or a concerning fetal heart-rate pattern through the obstetric team.

Limitations & cautions

The review pooled trials with differing regimens, populations, protocols, and risk of bias. It included pregnancies from 34 weeks onward without contraindications to vaginal birth, so the estimates do not determine the safest agent, route, or dose for an individual patient.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Journal of Obstetrics and Gynaecology Research (PubMed). Oral Misoprostol Versus Vaginal Dinoprostone for Labor Induction: A Systematic Review and Meta-Analysis.

Explain this for my unit

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Pharmacoepidemiology and Drug Safety (PubMed)Jul 23, 2026Research ArticlePractice applicable

A self-controlled analysis of linked US nursing-home assessments and Medicare claims identified major-bleeding signals involving clopidogrel and oral anticoagulants, but expert review judged only four medication pairs biologically plausible and bias checks raised caution about causal interpretation.

Geriatrics Med-SurgAI summaryReview source

Research ArticleResearchMedication SafetyWorkflowPractice applicableAI summary · original source linked below

After statistical adjustment, 14 of the screened medication pairs remained associated with major bleeding. Expert reviewers considered clopidogrel with sertraline and warfarin with cephalexin, sulfamethoxazole-trimethoprim, or furosemide biologically plausible. Signals involving the negative-control fall-injury outcome suggested that illness-related prescribing or other residual bias could explain some associations.

Key takeaways

The study compared residents' periods of concomitant medication use with periods using clopidogrel, apixaban, rivaroxaban, or warfarin alone.
Fourteen statistically adjusted signals remained, but only four were judged biologically plausible by an expert panel.
The plausible pairs were clopidogrel with sertraline and warfarin with cephalexin, sulfamethoxazole-trimethoprim, or furosemide.
Negative-control findings indicate that the signals are prompts for assessment, not proof that a medication pair caused bleeding.

Why this matters on shift

Nurses in long-term care reconcile complex regimens, monitor for bleeding, and communicate medication changes across prescribers, pharmacies, and care transitions. The study offers population-specific signals that can sharpen review while underscoring the danger of treating claims-based associations as automatic stop orders.

Bedside takeaway

Four antithrombotic medication pairs merit careful review, but the observed bleeding signals do not establish causation.

Nursing implications

During medication reconciliation or a change in therapy, identify concurrent antithrombotic and newly added medications, assess for bleeding or acute illness, and route concerns to the prescriber and pharmacist. Do not hold or discontinue therapy solely because a pair appeared in this screening study.

Limitations & cautions

The analysis used US nursing-home and Medicare claims from 2013 through 2020 and screened associations rather than testing medication changes. Residual confounding was evident in negative-control results, and the abstract does not establish absolute risk, causality, or the benefit of acting on any individual signal.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Pharmacoepidemiology and Drug Safety (PubMed). Drug-Drug Interaction Signals for Major Bleeding in Nursing Home Residents: High-Throughput Screening of Clopidogrel and Oral Anticoagulants.

Explain this for my unit

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

Frontiers in psychiatry (PubMed)Jul 10, 2026Systematic ReviewPractice applicable

A systematic review and meta-analysis of 14 observational studies involving 12,920 people found limited long-term stability after an initial diagnosis of acute and transient psychotic disorder, with diagnostic change and relapse common during follow-up.

PsychAI summaryReview source

Systematic ReviewResearchWorkflowPatient EducationPractice applicableAI summary · original source linked below

The pooled diagnostic-stability estimate was 41%, while 50% of patients experienced some diagnostic change and 43% experienced relapse. Transition to a schizophrenia-spectrum disorder was more common than transition to a mood disorder. Substantial heterogeneity across studies limits applying these pooled proportions to an individual patient or setting.

Key takeaways

Fourteen observational studies with 12,920 participants contributed long-term follow-up data.
The pooled diagnostic-stability estimate was 41%, and half of patients experienced some diagnostic change.
Transitions to schizophrenia-spectrum disorders were more frequent than transitions to mood disorders.
High between-study heterogeneity limits precise prognostic estimates for an individual patient.

Why this matters on shift

Mental-health nurses often observe symptom course, function, medication response, adverse effects, substance use, and relapse signals across settings and over time. The findings reinforce treating an early label as provisional and preserving high-quality longitudinal observations for future diagnostic review.

Bedside takeaway

Early acute-psychosis diagnoses were often unstable, making careful longitudinal observation and follow-up clinically important.

Nursing implications

Document current symptoms, function, sleep, substance use, treatment response, and collateral information without presenting the initial diagnosis as fixed. Reinforce follow-up plans and escalate relapse, deterioration, or safety concerns through the responsible mental-health team.

Limitations & cautions

The evidence was observational and pooled studies with different diagnostic systems, populations, settings, follow-up periods, and outcome definitions. Heterogeneity was substantial, pooled proportions cannot predict one person's course, and the abstract does not establish which follow-up model improves outcomes.
AI-summarized from the linked source. Review the original article before applying to practice.

Citations · exact source links

Frontiers in psychiatry (PubMed). Diagnostic stability and long-term outcomes of acute and transient psychotic disorders: a systematic review and meta-analysis.

Explain this for my unit

Open original sourceFull brief

AI-summarized from the linked source. Review the original article before applying to practice.

How This Applies in Practice

Key takeaways

Practice implications

Limitations & cautions

Exact source links

More updates for this clinical area

Labor-induction review found different tradeoffs for oral misoprostol and vaginal dinoprostone

Nursing-home study flagged four plausible medication pairs for major bleeding review

Acute psychosis diagnoses often changed over time, supporting longitudinal follow-up